TGIA
NVO

Torrey Growth & Income Advisors’s Novo Nordisk NVO Stock Holding History

Torrey Growth & Income Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.64M Sell
55,006
-777
-1% -$33.4K 0.9% 22
2026
Q1 		$2.02M Buy
55,783
+17,890
+47% +$848K 0.85% 24
2025
Q4 		$1.93M Buy
37,893
+32,992
+673% +$1.69M 0.67% 29
2025
Q3 		$272K Buy
+4,901
New +$287K 0.08% 100

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Torrey Growth & Income Advisors's NVO Position: Q2 2026 in Review

Torrey Growth & Income Advisors reduced its Novo Nordisk (NVO) stake by 1.4% in Q2 2026, selling an estimated $33.4K and leaving 55,006 shares worth $2.64M. The position accounts for 0.9% of the portfolio, ranked #22.

Torrey Growth & Income Advisors first reported a position in NVO in Q3 2025 and has held it in 4 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Torrey Growth & Income Advisors held 55,006 shares of Novo Nordisk worth $2.64M as of Q2 2026.
  • Torrey Growth & Income Advisors sold 777 Novo Nordisk shares in Q2 2026, an estimated $33.4K.
  • Novo Nordisk made up 0.9% of Torrey Growth & Income Advisors's portfolio in Q2 2026, its #22 holding.
  • Torrey Growth & Income Advisors first reported a position in Novo Nordisk in Q3 2025 and has held it in 4 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Torrey Growth & Income Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.